ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-33579

OpenClaw before 2026.3.28 contains a privilege escalation vulnerability in the /pair approve command path that fails to forward caller scopes into the core approval check.

Published Mar 31, 2026 · catalog updated Jul 24, 2026 · OpenClaw before 2026.3.28 contains

Check if you run it

No confirmed exploitation is on record for CVE-2026-33579. EPSS is 0.51%. Act only if a listed version of OpenClaw before 2026.3.28 contains is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (OpenClaw before 2026.3.28 contains).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.4
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.51%
Remediation
Advisory link
Affected products
cpe openclaw/openclaw

OpenClaw before 2026.3.28 contains a privilege escalation vulnerability in the /pair approve command path that fails to forward caller scopes into the core approval check. A caller with pairing privileges but without admin privileges can approve pending device requests asking for broader scopes including admin access by exploiting the missing scope validation in extensions/device-pair/index.ts and src/infra/device-pairing.ts.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe openclaw/openclawversion unspecified

How to fix CVE-2026-33579

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-33579. EPSS is 0.51%. Act only if a listed version of OpenClaw before 2026.3.28 contains is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-863: Incorrect Authorization. EPSS 0.51%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 31, 2026 · NIST NVD

    Detected

    OpenClaw before 2026.3.28 contains a privilege escalation vulnerability in the /pair approve command path that fails to forward caller scopes into the core approval check. A caller with pairing privileges but without admin privileges can approve pending device requests asking for broader scopes including admin access by exploiting the missing scope validation in extensions/device-pair/index.ts and

  2. Jul 24, 2026 · NIST NVD

    Updated

    OpenClaw before 2026.3.28 contains a privilege escalation vulnerability in the /pair approve command path that fails to forward caller scopes into the core approval check. A caller with pairing privileges but without admin privileges can approve pending device requests asking for broader scopes including admin access by exploiting the missing scope validation in extensions/device-pair/index.ts and

Sources

  • CVE.orgVulnerability recordCVE-2026-33579

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-33579

    30-day exploitation probability 0.5%

    first.org
  • NIST NVDVulnerability recordCVE-2026-33579

    OpenClaw before 2026.3.28 contains a privilege escalation vulnerability in the /pair approve command path that fails to forward caller scopes into the core approval check. A caller with pairing privileges but without admin privileges can approve pending device requests asking for

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.